p62 (SQSTM1) forms part of a novel, reversible aggregate containing a specific conformer of the cAMP degrading phosphodiesterase, PDE4A4.

Autophagy

Molecular Pharmacology Group, Wolfson Link and Davidson Buildings, Institute of Neuroscience and Psychology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotand, UK.

Published: November 2010

Cells employ macroautophagy to deliver aggregates of misfolded and/or ubiquitinated proteins for lysosomal degradation or supply of essential macromolecules under conditions of nutrient deprivation. The former seems complementary to the proteasome system, which is likely to degrade only soluble proteins. While bulk degradation via the autophagy pathway during starvation is rather nonspecific, the recognition of proteins that are either misfolded or adopt a particular conformation and/or become ubiquitinated, requires some form of specificity. This is brought about, at least in part, by the scaffold and ubiquitin-binding protein, p62 (SQSTM1). p62 is a multidomain scaffold that sequesters other proteins and polymerizes through its Phox and Bem1p domains and binds K63-ubiquitinated proteins through its UBA domain. p62 interaction with LC3 appears critical for membrane encapsulation seen in autophagosomes. However, there is a growing body of evidence indicating that p62 is not exclusively involved in autophagy regulation, and that there are nonmembrane encapsulated, soluble subpopulations of p62 in cells. The role of these subpopulations has yet to be resolved, although one function appears to be to regulate signaling, as indicated through p62's ability to regulate NFκB activation. Signaling through the ubiquitous cyclic AMP (cAMP) system is compartmentalized, with tethered subpopulations of cAMP-degrading phosphodiesterases sculpting cAMP gradients around specific signaling complexes so as to regulate them at a spatial level. We have recently demonstrated that p62 colocalizes with a specific conformer of the cAMP degrading phosphodiesterase, PDE4A4, so as to form reversible, membrane-free cytosolic aggregates lacking LC3. This results in PDE4A4 becoming sequestered away from signaling proteins that normally sequester it, providing a means of reprogramming compartmentalized cAMP signaling in cells.

Download full-text PDF

Source
http://dx.doi.org/10.4161/auto.6.8.13479DOI Listing

Publication Analysis

Top Keywords

p62 sqstm1
8
specific conformer
8
conformer camp
8
camp degrading
8
degrading phosphodiesterase
8
phosphodiesterase pde4a4
8
and/or ubiquitinated
8
p62
7
proteins
6
camp
5

Similar Publications

We present functional studies of lysosomes in human cells after uptake of carbon nanodots (CNDs). Even under high CND concentrations, the lysosomal functionality, as characterized via cathepsins B and L as well as the autophagic markers SQSTM1/p62 and LC3B-II, is maintained. Furthermore, branched polyethylenimine (bPEI) molecules have been coupled to the CNDs as a model functionalization or example of a drug.

View Article and Find Full Text PDF

Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis.

Trends Biochem Sci

January 2025

Jacqui Wood Cancer Centre, Division of Cancer Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK. Electronic address:

Transcription factor NF-E2 p45-related factor 2 (Nrf2) orchestrates defenses against oxidants and thiol-reactive electrophiles. It is controlled at the protein stability level by several E3 ubiquitin ligases (CRL3, CRL4, SCF, and Hrd1). CRL3 is of the greatest importance because it constitutively targets Nrf2 for proteasomal degradation under homeostatic conditions but is prevented from doing so by oxidative stressors.

View Article and Find Full Text PDF

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo.

Pharmaceutics

December 2024

Department of Experimental Therapeutics, BC Cancer, Vancouver, BC V5Z 1L3, Canada.

Preclinical studies have shown that the anti-malarial drug hydroxychloroquine (HCQ) improves the anti-cancer effects of various therapeutic agents by impairing autophagy. These findings are difficult to translate in vivo as reaching an effective HCQ concentration at the tumor site for extended times is challenging. Previously, we found that free HCQ in combination with gefitinib (Iressa, ZD1839) significantly reduced tumor volume in immunocompromised mice bearing gefitinib-resistant JIMT-1 breast cancer xenografts.

View Article and Find Full Text PDF

Oxidative stress, endoplasmic reticulum (ER) stress, and alterations in autophagy activity have been described as prominent factors mediating many pathological processes in chronic kidney disease (CKD). The accumulation of misfolded proteins in the ER may stimulate the unfolded protein response (UPR). The interplay between autophagy and UPR in hemodialysis (HD) patients remains unclear.

View Article and Find Full Text PDF

The Role of Autophagy in Copper-Induced Apoptosis and Developmental Neurotoxicity in SH-SY5Y Cells.

Toxics

January 2025

Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.

Copper (Cu) is a global environmental pollutant that poses a serious threat to humans and ecosystems. Copper induces developmental neurotoxicity, but the underlying molecular mechanisms are unknown. Neurons are nonrenewable, and they are unable to mitigate the excessive accumulation of pathological proteins and organelles in cells, which can be ameliorated by autophagic degradation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!